Cargando…
Targeting the neuronal calcium sensor DREAM with small-molecules for Huntington’s disease treatment
DREAM, a neuronal calcium sensor protein, has multiple cellular roles including the regulation of Ca(2+) and protein homeostasis. We recently showed that reduced DREAM expression or blockade of DREAM activity by repaglinide is neuroprotective in Huntington’s disease (HD). Here we used structure-base...
Autores principales: | Lopez-Hurtado, Alejandro, Peraza, Diego A., Cercos, Pilar, Lagartera, Laura, Gonzalez, Paz, Dopazo, Xose M., Herranz, Rosario, Gonzalez, Teresa, Martin-Martinez, Mercedes, Mellström, Britt, Naranjo, Jose R., Valenzuela, Carmen, Gutierrez-Rodriguez, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514012/ https://www.ncbi.nlm.nih.gov/pubmed/31086218 http://dx.doi.org/10.1038/s41598-019-43677-7 |
Ejemplares similares
-
Inhibition of the Neuronal Calcium Sensor DREAM Modulates Presenilin-2 Endoproteolysis
por: Naranjo, Rocío, et al.
Publicado: (2018) -
Inhibition of DREAM-ATF6 interaction delays onset of cognition deficit in a mouse model of Huntington’s disease
por: López-Hurtado, Alejandro, et al.
Publicado: (2018) -
Identification of IQM-266, a Novel DREAM Ligand That Modulates K(V)4 Currents
por: Peraza, Diego A., et al.
Publicado: (2019) -
Specific cytoarchitectureal changes in hippocampal subareas in daDREAM mice
por: Mellström, Britt, et al.
Publicado: (2016) -
Reduced Mid1 Expression and Delayed Neuromotor Development in daDREAM Transgenic Mice
por: Dierssen, Mara, et al.
Publicado: (2012)